Virtu Financial LLC Geo Vax Labs, Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$0.55 - $0.75 $14,903 - $20,322	27,097 New	27,097 $15,000
Q3 2022 Nov 07, 2022	SELL	$0.4 - $58.5 $1,838 - $268,807	-4,595 Reduced 6.65%	64,498 $70,000
Q2 2022 Aug 09, 2022	BUY	$9.29 - $34.8 $180,309 - $675,433	19,409 Added 39.06%	69,093 $57,000
Q1 2022 May 17, 2022	BUY	$17.25 - $58.95 $857,049 - $2.93 Million	49,684 New	49,684 $57,000
Q2 2021 Sep 17, 2021	SELL	$64.8 - $94.5 $3.92 Million - $5.72 Million	-60,493 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$49.05 - $126.6 $2.33 Million - $6.02 Million	47,546 Added 367.24%	60,493 $265,000
Q4 2020 Feb 24, 2021	BUY	$39.45 - $85.95 $510,759 - $1.11 Million	12,947 New	12,947 $44,000

Ticker GOVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,744,000
Market Cap $55.9M
Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.